Ken Griffin’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-261,097
| Closed | -$1.18M | – | 13159 |
|
|
2025
Q4 | $1.18M | Buy |
261,097
+144,033
| +123% | +$738K | ﹤0.01% | 7028 |
|
|
2025
Q3 | $631K | Buy |
+117,064
| New | +$633K | ﹤0.01% | 8571 |
|
|
2024
Q4 | – | Sell |
-1,011,537
| Closed | -$2.92M | – | 14642 |
|
|
2024
Q3 | $2.97M | Buy |
1,011,537
+751,007
| +288% | +$2.47M | ﹤0.01% | 4796 |
|
|
2024
Q2 | $886K | Sell |
260,530
-719,974
| -73% | -$2.35M | ﹤0.01% | 6833 |
|
|
2024
Q1 | $2.97M | Buy |
980,504
+78,006
| +9% | +$274K | ﹤0.01% | 4809 |
|
|
2023
Q4 | $3.8M | Sell |
902,498
-2,171,495
| -71% | -$11.8M | ﹤0.01% | 4224 |
|
|
2023
Q3 | $21M | Buy |
3,073,993
+720,193
| +31% | +$6.36M | ﹤0.01% | 1809 |
|
|
2023
Q2 | $24.5M | Sell |
2,353,800
-581,503
| -20% | -$5.2M | 0.01% | 1683 |
|
|
2023
Q1 | $20.5M | Buy |
2,935,303
+954,433
| +48% | +$8.32M | ﹤0.01% | 1892 |
|
|
2022
Q4 | $11.9M | Buy |
1,980,870
+1,909,554
| +2,678% | +$14.1M | ﹤0.01% | 2572 |
|
|
2022
Q3 | $562K | Sell |
71,316
-53,014
| -43% | -$618K | ﹤0.01% | 8202 |
|
|
2022
Q2 | $1.69M | Sell |
124,330
-172,270
| -58% | -$2.85M | ﹤0.01% | 5887 |
|
|
2022
Q1 | $5.82M | Buy |
296,600
+279,368
| +1,621% | +$5.58M | ﹤0.01% | 3885 |
|
|
2021
Q4 | $591K | Sell |
17,232
-42,899
| -71% | -$1.73M | ﹤0.01% | 9272 |
|
|
2021
Q3 | $3.29M | Buy |
60,131
+51,585
| +604% | +$3.11M | ﹤0.01% | 5163 |
|
|
2021
Q2 | $628K | Buy |
8,546
+5,624
| +192% | +$562K | ﹤0.01% | 9505 |
|
|
2021
Q1 | $267K | Sell |
2,922
-14,332
| -83% | -$1.39M | ﹤0.01% | 11107 |
|
|
2020
Q4 | $1.4M | Buy |
+17,254
| New | +$1.32M | ﹤0.01% | 6081 |
|
Ken Griffin's CVAC Position: Q1 2026 in Review
Ken Griffin sold out of CureVac (CVAC) in Q1 2026, closing a stake of 261,097 shares — an estimated $1.18M sold.
Ken Griffin first reported a position in CVAC in Q4 2020 and held it in 18 quarters. The position peaked at $24.5M in Q2 2023. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Ken Griffin reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Ken Griffin sold 261,097 CureVac shares in Q1 2026, an estimated $1.18M.
- Ken Griffin first reported a position in CureVac in Q4 2020 and held it in 18 quarters.
- Ken Griffin's CureVac position peaked at $24.5M in Q2 2023.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.